Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
Blinded, multicenter, placebo-controlled, randomized clinical trial evaluating
lopinavir/ritonavir vs placebo in early outpatient treatment of adults with COVID-19